BioCorRx, Inc. Completes License Agreement for Distribution of its Start Fresh Program in Minnesota, Missouri, and Oklahoma
27 Junho 2014 - 4:36PM
BioCorRx, Inc. ('the Company") (OTCQB: BICX), a leader in addiction
treatment and rehabilitation programs, announced it has closed the
sale for the exclusive license and distribution rights of its Start
Fresh Program to multiple wholly owned subsidiaries of Start Fresh
Midwest Holdings, LLC, which consist of common majority owners of
Fresh Start Private Midwest, LLC. ("Midwest"). Under
the terms of the finalized agreement, Midwest will pay BioCorRx,
Inc. an upfront license fee plus an ongoing fee per program ordered
in the states of Minnesota, Missouri, and Oklahoma.
The combined population of these states is over
15 million people, many of which can benefit from the Start Fresh
Program. Minnesota has seen such an increase in opiate
addiction that earlier this year the state passed legislation
offering immunity from prosecution to those who call for help
during an overdose. Along with this new legislation the state
also offers training in the administration of overdose reversing
drugs to friends, family, and first responders who deal with
addicts. Minnesota has also been ranked third in a list of
states with the highest percentage of residents dependent on
alcohol by the Substance Abuse and Mental Health Services
Administration, an agency within the Federal Department of Health
and Human Services. According to the Centers for
Disease Control, Oklahoma ranks as one of the highest
states for prescription drug overdose deaths in the
nation. Impaired driving deaths are not only tragic,
but cost Missouri taxpayers approximately $1.4 billion
annually. Bringing the Start Fresh Program to
these three new states will positively impact many families
while creating a broader revenue stream for BioCorRx, Inc.
"We are very pleased with this latest license deal as it creates
more distribution points for our program so that more people can be
helped. This group currently operates in Nebraska, so their
ramp up period should be relatively reduced." said Kent Emry, CEO
of BioCorRx, Inc. "Our goal is to have our program
conveniently available to everyone and this is another step towards
achieving that goal."
Media
Click here to view Recent National Television Media on
the BioCorRx YouTube Channel
Click here for company Facebook page for more stories
and media coverage
About BioCorRx, Inc.
BioCorRx, Inc. (OTCQB: BICX) is an addiction
treatment and rehabilitation company on the leading edge of
addiction treatment. The company has developed a highly effective
program called the Start Fresh ProgramTM consisting of two
components used by various addiction clinics in the US. Clinic
reports show that the treatment program has an extremely high
success rate with individuals that complete the program. The first
component of the program consists of an outpatient implant
procedure performed by a licensed physician that delivers
therapeutic levels of the drug Naltrexone, an opioid antagonist
that significantly reduces physical cravings for alcohol and
opioids, into the body. The second component of the program
developed by BioCorRx, Inc. is a one on one coaching program
specifically tailored for the treatment of alcoholism and other
substance abuse addictions. For more information on BICX, visit
www.BioCorRx.com.
Safe Harbor Statement
The information in this release includes
forward-looking statements. These forward-looking statements
generally are identified by the words "believe," "project,"
"estimate," "become," "plan," "will," and similar expressions.
These forward-looking statements involve known and unknown risks as
well as uncertainties, including those discussed in the following
cautionary statements and elsewhere in this release. Although the
Company believes that its expectations are based on reasonable
assumptions, the actual results that the Company may achieve may
differ materially from any forward-looking statements, which
reflect the opinions of the management of the Company only as of
the date hereof.
CONTACT: Investor Relations
SmallCapVoice.com, Inc.
512-267-2430
BioCorRx (QB) (USOTC:BICX)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
BioCorRx (QB) (USOTC:BICX)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024